TickerFactsScreenerDevelopers

Cocrystal Pharma, Inc. (COCP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2012: -$1.59M2013: -$3.69M2014: -$6.01M2015: -$10.32M2016: -$14.65M2017: -$6.90M2018: -$8.29M2019: -$1.56M2020: -$9.83M2021: -$12.72M2022: -$21.43M2023: -$14.67M2024: -$16.48M2025: -$8.19M-$8.19M
2012Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$8.19M+50.3%
2024-$16.48M-12.4%
2023-$14.67M+31.6%
2022-$21.43M-68.5%
2021-$12.72M-29.4%
2020-$9.83M-528.9%
2019-$1.56M+81.1%
2018-$8.29M-20.1%
2017-$6.90M+52.9%
2016-$14.65M-42.0%
2015-$10.32M-71.6%
2014-$6.01M-63.1%
2013-$3.69M-132.0%
2012-$1.59M—